x vivo culture of adult bone marrow (BM) or peripheral blood sources of human CD34 + cells with cytokines has been reproducibly associated with the loss of primitive repopulating cells over time. 1, 2 severe combined immunodeficiency (SCID)-repopulating cells (SRCs) may have been contained within the CD34 fraction. But this was not measurable since heterogeneous CD34 cells (enriched CFU-GEMM and CFU-GM) were used in these studies.
Following liquid suspension culture with cytokines including granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin 3 (IL-3), IL-6, stem cell factor (SCF) and erythropoietin (EPO), our previous work found that the CD34 + cells showed a significant loss of early hematopoietic progenitor cells. 3 In contrast, the hematopoietic inhibitors, thymosin β4, MIP-1α or TGF-β induce the expansion of early hematopoietic progenitor cells when they are cultured in a liquid culture system containing hematopoietic stimulators. [3] [4] [5] [6] MSP has potent suppressive activity for immature subsets of bone marrow myeloid progenitor cells and for cord blood cells that were induced into rapid cell cycle. 7 Our previous work showed that MSP mRNA was expressed in murine bone marrow endothelial cells and MSP protein was secreted into murine bone marrow endothelial cell condition medium (BMEC-CM). 3, 8 It is not yet known whether MSP will induce the expansion of the early hematopoietic cells in liquid culture. The aim of this study was to observe the inhibitory effects of MSP on hematopoietic cells and the expansion effect on the early hematopoietic progenitor cells.
METHODS

Human bone marrow CD34 + cells
Human bone marrow cells were obtained from ribs excised during chest operations of hematologically normal donors. Approved institutional procedures involving written informed consent from each patient were followed. BM mononuclear cells (MNC) were separated by Ficoll-Paque (1.077 g/ml) density gradient centrifugation. CD34 + cells were purified (>90%) by positive selection using a MACS (Miltenyi Biotech, Bergish-Gladbach, Germany) according to the manufacturer's instructions. Cells were placed in Iscove modified Dulbecco medium (IMDM) containing 10% fetal bovine serum (FBS), 100 U/ml penicillin and 100 µg/ml streptomycin at 37˚C.
Culture of bone marrow endothelial cells
BM endothelial cell line cells were cultured as previously described. 9 Briefly, 5×10 4 endothelial cell line cells were cultured on fibronectin-coated wells of a 6-well plate in IMDM containing 15% FBS, 100 U/ml penicillin and 100 µg/ml streptomycin at 37˚C in 5% CO 2 atmosphere. Culture medium was replaced every 3 days. Cells were cultured in medium for more than 10 days for the formation of endothelial cell monolayer. The serum free endothelial cell conditioned medium (EC-CM) was collected from the endothelial cell culture. EC-CM was ultrafiltered through a Centriprep 10 concentrator (Amicon Inc., Beverly, MA, USA), with a 10 kD cut-off. The retentate was >10 kD component.
Colony-forming assays
CFU-GM was the later progenitor of hematopoietic cells. For CFU-GM culture, 1×10 3 to 4×10 4 cells/well were cultured with a 0.9% methylcellulose-culture medium containing rhGM-CSF (100 ng/ml) or GM-CSF (100 ng/ml) plus Flt3-L (100 ng/ml) with or without rhMSP and maintained at 37˚C in 5% CO 2 atmosphere. Colonies were scored after incubation for 14 days. CFU-GEMM was the earlier progenitor of hematopoietic cells. For CFU-GEMM culture, cells were cultured with a 0.9% methylcellulose-culture medium containing rhEPO (2 U/ml), rhSCF (50 ng/ml), rhIL-3 (50 ng/ml), rhIL-6 (50 ng/ml), rhGM-CSF (100 ng/ml) with or without rhMSP (all from R&D System, USA). Colonies were scored after incubation at 37˚C in 5% СО 2 atmosphere for 21 days.
Liquid culture for CD34 + cell
For assay of the effects of MSP on the expansion of early hematopoietic progenitor cells, CFU-GEMM, twenty thousand BM CD34 + cells were added into the medium containing 15% FBS, rhEPO (2 U/ml), rhSCF (50 ng/ml), rhIL-3 (50 ng/ml), rhIL-6 (50 ng/ml), rhGM-CSF (50 ng/ml), with or without rhMSP (100 ng/ml), and maintained at 37˚C in 5% CO 2 atmosphere. After 6 days of culture cells were harvested and counted and then cultured in a 0.9% methylcellulose culture medium for assay of the number of CFU-GM and CFU-GEMM. The number of CFU-GM or CFU-GEMM from freshly isolated CD34 + cells was used as the control (100%).
Nitroblue tetrazolium (NBT) reductive test
CD34 + bone marrow cells were cultured at 37˚C in flat-bottomed 24-well plates in a stroma-free liquid culture system for 6 days. The cells were collected and resuspended in 200 μl of NBT liquid in the presence of tissue plasminogen activator (TPA), 0.24 µg/ml, then cultured at 37˚C for 1 hour. Cells were centrifuged and collected for the NBT assay.
Hoechest 33258 staining CD34 + bone marrow cells were cultured at 37˚C in a stroma-free liquid culture system for 6 days, washed with PBS 3 times, smeared, fixed with formaldehyde, covered with Hoechest 33258 (Molecular Probes Inc., Eugene, USA) then cultured at 37˚C for 15 minutes. We observed and counted the apoptotic cells under a fluorescence microscope.
MSP antibody neutralization assay
The >10 kD component of EC-CM was pre-incubated with antibody against MSP (R&D System). After pre-incubation, the 10 kD of EC-CM was added to the semi-solid culture system for the CFU-GM and CFU-GEMM assay. The 10 kD component of EC-CM, pre-incubated without antibody against MSP, was added as a control. CFU-GM were cultured by adding the >10 kD EC-CM alone and the CFU-GEMM were cultured by adding the >10 kD EC-CM plus GM-CSF. 10
RT-PCR
RT-PCR was used to detect mRNA encoding MSP in bone marrow endothelial cells. RNA was prepared from bone marrow endothelial cells. Primer sequences of MSP were: Forward 5'-CCCTAGTGAAGGAGCAGTGG-3'; Reverse 5'-CCAGCTGCATGACCTTGTTA-3'.The PCR product was 604 bp and examined on a 1.5% gel and photographed.
Statistical analysis
Results were expressed as mean ± standand deviation (SD). Levels of significance were determined using the Student's t test. A P value less than 0.05 was considered significantly different.
RESULTS
Inhibitory effect of MSP on the growth of hematopoietic progenitor cells
CFU-GM and CFU-GEMM were cultured in a 0.9% methylcellulose-culture medium and the effect of MSP (100 ng/ml) on the growth of CFU-GM and CFU-GEMM was investigated. The results showed that MSP could inhibit the growth of CFU-GM and CFU-GEMM. MSP exerted a higher inhibitory effect on CFU-GM colony formation induced by synergistic combinations of GM-CSF plus Flt3-L than by GM-CSF only ( Fig. 1 ). MSP exerted a stronger inhibitory effect on CFU-GEMM than on CFU-GM ( Fig. 2 ).
Effect of early hematopoietic factors on the role of MSP
CFU-GM was cultured in a 0.9% methylcellulose-culture medium. MSP, at 75 g/ml, had an inhibitory effect on the CFU-GM formation induced by GM-CSF only and reached a peak at 100 ng/ml ( Fig. 3 ). While CFU-GM formation was induced by both GM-CSF and Flt3-L, MSP had an inhibitory effect at 50 ng/ml and reached the peak at 100 ng/ml (Fig. 3 ). The inhibitory effect was dose-dependent. 
Influence of MSP on the growth of early hematopoietic progenitor cells cultured in an in vitro liquid system
After 6 days in culture with different liquid culture conditions, the numbers of CFU-GM and CFU-GEMM were analyzed. The results showed that the numbers of CFU-GM were significantly increased in the cytokines group (EPO+SCF+IL-3+IL-6+GM-CSF), cytokines+ MSP group (EPO+SCF+IL-3+IL-6+GM-CSF+MSP) and cytokines+EC-CM group (Fig. 4) . The CFU-GEMM was significantly decreased in the cytokines group and increased in the cytokines + MSP group and the cytokines+EC-CM group (Fig. 5) . 
Influence of MSP on the differentiation and apoptosis of CD34 + cells cultured in an in vitro liquid system
An NBT reductive test and hoechest 33258 staining were employed to investigate the influence of MSP on the differentiation and apoptosis of CD34 + cells after the cells were cultured in different liquid systems for 6 days. The NBT reductive test can detect the cell differentiation. And the hoechest 33258 staining reflects the apoptosis of cells. The results showed that MSP had no obvious effect on the CD34 + cells apoptosis, but when adding MSP to the liquid culture system, a lower differentiation percent was observed. The NBT positive cell percent for the cytokines group was (22.75±3.60)% and that of the MSP + cytokines group was (12.25± 3.43)% (P<0.05).
Comparison between the effects of MSP and MIP-1α on the growth of hematopoietic progenitor cells
After CD34 + cells were cultured in the presence of EPO+SCF+IL-3+IL-6+GM-CSF (Cys group) or in the presence of EPO+SCF+IL-3+IL-6+GM-CSF+MSP (MSP+Cys group) or in the presence of EPO+SCF+IL-3+IL-6+GM-CSF+MIP-1α (MIP-1α+Cys group) for 6 days, an assay of the numbers of CFU-GM and CFU-GEMM, the NBT reductive test, to assay differentiation, and the hoechest 33258, staining for apoptosis, were done. The results showed that compared with the Cys group the numbers of CFU-GEMM were increased and the differentiation of CD34 + cells was decreased in both the MSP+Cys group and the MIP-1α+Cys group. There was no significant difference between the MSP+Cys group and MIP-1α+Cys group (Table) . .47 Bone marrow CD34 + cells were cultured in different liquid culture system for 6 days. *P<0.05, **P<0.01 vs Cys group. Cys: EPO+SCF+IL-3+IL-6+GM-CSF; MIP-1α+Cys: EPO+SCF+IL-3+IL-6+GM-CSF+MIP-1α; MSP+Cys: EPO+SCF +IL-3+IL-6+GM-CSF+MSP. CFU-GM: granulocyte-macrophage colony forming unit; CFU-GEMM: colony forming unit-granulocyte, erythrocyte, macrophage, megakaryocyte; NBT: nitroblue tetrazolium.
Biological activity assay of MSP in BMEC-CM
RT-PCR analysis showed that endothelial cells expressed MSP mRNA (Fig. 6 ). The >10 kD component of EC-CM pre-treated with antibody to MSP was used to study the biological activity of MSP (>10 kD) in conditioned medium. CFU-GM or CFU-GEMM could be formed by adding >10 kD EC-CM alone or >10 kD EC-CM plus GM-CSF respectively. 10 Using this method for cultivation of CFU-GM and CFU-GEMM, the results showed that the formation of CFU-GM and CFU-GEMM in the group of >10 kD EC-CM treated with antibody were higher than in the untreated group (Fig. 6 ).
DISCUSSION
The expansion of CD34 + cells in vitro has a potential role in hematopoietic transplantation and gene therapy. However, recent studies have suggested that the expansion of CD34 + cells in in vitro culture with several combinations of hematopoietic stimulating factors was associated with a significant loss of early hematopoietic progenitor cells. [3] [4] [5] [6] 11 The progenitors were expanded by several-fold when CD34 + cells were cultured with the same hamatopoietic stimulating factors but plus early hematopoietic inhibitors such as TGF-β, MIP-1α and Tβ4. [3] [4] [5] [6] In this study we have first demonstrated that the early hematopoietic progenitor cells, CFU-GEMMs, which were correlated with amplification of HSC, were expanded in a liquid culture system with hematopoietic stimulating factors SCF, IL-3, IL-6, GM-CSF and EPO plus hematopoietic inhibitor MSP. MSP is a heterodimeric protein consisting of a disulfide-linked 53-kD α-chain and 25-kD β-chain. The MSP receptor is a transmembrane tyrosine kinase called RON in humans and STK in mice. The MSP receptor is expressed on hematopoietic cells. 12 Broxmeyer et al 7 investigated the effect of MSP on myeloid progenitor cells and umbilical stem cells and the results showed that MSP had potent suppressive activity for early hematopoietic progenitor cells that were induced into rapid cell cycle. The former work of our laboratory suggested that MSP was an inhibitor secreted by murine bone marrow endothelial cells. 3, 8 In this study our results showed that MSP could inhibit the growth of CFU-GM and CFU-GEMM. MSP exerted a stronger inhibitory effect on CFU-GEMM than on CFU-GM and a higher inhibitory effect on CFU-GM colony formation induced by synergistic combinations of GM-CSF plus Flt3-L than by GM-CSF only. This suggests that the inhibitory effect of MSP was enhanced in the presence of an early hematopoietic cytokine. MSP suppressed the growth of CFU-GM, starting at 75 ng/ml when stimulated by GM-CSF alone and at 50 ng/ml when stimulated by GM-CSF plus Flt3-L. In the presence of early hematopoietic cytokine, MSP could exert inhibition at a lower concentration.
Self-renewal division of hematopoietic stem cell (HSC) enables simultaneous sustained production of blood cells and maintenance of the stem cell pool. The balance of differentiation and self-renewal depended on the regulatory mechanisms including positive hematopoietic stimulators and negative hematopoietic inhibitors. [2] [3] [4] [5] [6] 13 In vitro stroma-free culture system for expansion of hematopoietic progenitors contains different cytokine combinations. One of the combinations is hematopoietic stimulators only. 13, 14 Another one is hematopoietic stimulators plus hematopoitic inhibitor(s). [3] [4] [5] [6] The combination of SCF, GM-CSF, IL-3, IL-6, EPO and IL-1 leads to the differentiation of HSCs and early HPCs and then decreases the number of HSC/HPC. 15, 16 The HSC/HPC increases when these cytokines combine with inhibitor(s). Tanosaki et al 4 reported that MIP-1α protected the repopulating ability of purified murine hematopoietic stem cells in serum-deprived cultures stimulated with SCF and IL-3. Sitnicka E et al 17 reported that the continuous presence of TGF-β, directly inhibits the cell division resulted in a maintenance of high proliferation potential-colony-forming cells (HPP-CFC) during 8 days of culture compared with a loss of HPP-CFC in cultures without TGFβ. This study showed that TGF-β directly inhibits the initial stages of proliferation of long-term repopulating cells (LTR-HSC) and appears to slow the differentiation of daughter cells of low Ho/Rh cells that are highly enriched for LTR-HSC. 17 Previous work from our laboratory also showed that MIP-1α and Tβ4 could protect early hematopoietic progenitor cells from differentiation in in vitro culture systems with growth cytokines. 3 In this paper we reported that MSP, combined with 5 hematopoietic cytokines (EPO+SCF+IL-3 +IL-6+GM-CSF), when added to CD34 + cell expansion liquid culture system, significantly increases CFU-GEMM compared with the 5 cytokine control group. This result indicates that MSP, a hematopoietic inhibitor, can protect the early hematopoietic cells from differentiation and makes them expand in culture supplemented with cytokines. The expansion effect of MSP on hematopoietic progenitor cells is similar as MIP-1α.
MSP is expressed in murine bone marrow endothelial cells and MSP protein was found in BMEC-CM. 3, 8 According to the results of our antibody neutralization experiment, MSP had inhibitory biological activity in EC-CM. BMEC-CM could expand the early hematopoietic progenitor cells and that effect was related to the inhibitors, including MSP, which exist in BMEC-CM. 3, 8 In this study the results showed that MSP can protect early hematopoietic cells and increase the number of early hematopoietic cells. So MSP plays a role in expansion of the early hematopoietic progenitor cells through by combining with hematopoietic stimulators.
The results of the NBT reductive test and hoechest 33258 staining showed that MSP suppresses the differentiation of HSC/HPC but had no significant effect on the apoptosis of hematopoietic cells. Taking together, MSP makes the early hematopoietic progenitor cells expand in a liquid expansion culture system mainly through effecting the differentiation and proliferation of early hematopoietic progenitor cells.
CFU-GEMM is a reliable indicator of HSC content and the expansion of this population correlates well with an increase in hematopoietic stem/progenitor cells. We anticipate that the results of this study will allow a more definitive characterization of human HSCs as they undergo expansion as well as define the role of MSP in the expansion of hematopoietic stem/progenitor cells.
